Literature DB >> 28105693

Epigenetic regulation of Wnt/β-catenin signal-associated genes in gastric neoplasia of the fundic gland (chief cell-predominant) type.

Takashi Murakami1,2, Hiroyuki Mitomi3, Takashi Yao2, Tsuyoshi Saito2, Tomoyoshi Shibuya1, Sumio Watanabe1.   

Abstract

Gastric neoplasia of the fundic gland (chief cell-predominant) type (GNCCP) is a rare variant of gastric tumor. This tumor is associated with activation of the Wnt/β-catenin signaling pathway; however, the mechanisms underlying this activation remain unknown. To elucidate potential roles of Wnt/β-catenin signal-associated gene methylation in GNCCP, we performed β-catenin immunostaining and methylation-specific polymerase chain reaction (PCR) for their associated genes, including SFRPs, APC, AXIN2, and MCC, in 26 GNCCPs [i.e., 11 intramucosal (GNCCP-Ms) and 15 submucosal tumors (GNCCP-SMs)], and compared with 27 fundic gland polyps (FGPs), 12 FGPs with dysplasia (FGP-Ds), 27 conventional gastric adenocarcinomas (CGAs). Nuclear β-catenin labeling indices were higher in GNCCPs and CGAs than in FGPs and FGP-Ds. SFRPs, APC, and AXIN2 were more frequently methylated in GNCCPs and CGAs (SFRP1, 88%/96%; SFRP2, 85%/93%; SFRP4, 73%/81%; APC, 81%/81%; AXIN2, 81%/85%; respectively) than in FGPs and FGP-Ds (37%/50%; 41%/42%; 41%/58%; 37%/33%; 41%/50%; respectively). A significant correlation was seen between nuclear β-catenin expression and methylation of SFRP1 in GNCCPs. Furthermore, nuclear β-catenin expression was significantly frequent in high-methylated GNCCPs than in low-methylated tumors. In conclusion, our results suggest that activation of this pathway, mediated by gene methylation, may be associated with progression of some GNCCP cases, similar to CGAs.
© 2017 Japanese Society of Pathology and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Wnt/β-catenin signaling pathway; epigenetic regulation; fundic gland polyp; gastric adenocarcinoma; gastric neoplasia of chief cell-predominant type

Mesh:

Year:  2017        PMID: 28105693     DOI: 10.1111/pin.12509

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  4 in total

1.  Clinicopathological and molecular characterization of early gastric adenocarcinoma in Helicobacter pylori-uninfected patients: emphasis on differentiated gastric adenocarcinoma.

Authors:  Yoichi Akazawa; Hiroya Ueyama; Takuo Hayashi; Hisanori Utsunomiya; Ryota Uchida; Daiki Abe; Shotaro Oki; Nobuyuki Suzuki; Atsushi Ikeda; Noboru Yatagai; Hiroyuki Komori; Tsutomu Takeda; Kohei Matsumoto; Kumiko Ueda; Kenshi Matsumoto; Daisuke Asaoka; Mariko Hojo; Tsuyoshi Saito; Takashi Yao; Akihito Nagahara
Journal:  J Gastroenterol       Date:  2022-08-08       Impact factor: 6.772

Review 2.  Gastric adenocarcinoma of fundic gland type with signet-ring cell carcinoma component: A case report and review of the literature.

Authors:  Keita Kai; Masaaki Satake; Osamu Tokunaga
Journal:  World J Gastroenterol       Date:  2018-07-14       Impact factor: 5.742

Review 3.  Gastric adenocarcinoma of the fundic gland: A review of clinicopathological characteristics, treatment and prognosis.

Authors:  Xiang-Yu Meng; Guang Yang; Cheng-Ji Dong; Ru-Yi Zheng
Journal:  Rare Tumors       Date:  2021-12-14

4.  Gastric epithelial neoplasm of fundic-gland mucosa lineage: proposal for a new classification in association with gastric adenocarcinoma of fundic-gland type.

Authors:  Hiroya Ueyama; Takashi Yao; Yoichi Akazawa; Takuo Hayashi; Koichi Kurahara; Yumi Oshiro; Masayoshi Yamada; Ichiro Oda; Shin Fujioka; Chiaki Kusumoto; Masayoshi Fukuda; Kunihisa Uchita; Tomohiro Kadota; Yasuhiro Oono; Kazuhisa Okamoto; Kazunari Murakami; Yasumasa Matsuo; Motohiko Kato; Tadateru Maehata; Naohisa Yahagi; Yumiko Yasuhara; Tomoyuki Yada; Koji Uraushihara; Tetsumi Yamane; Taiji Matsuo; Masanori Ito; Yasuhiko Maruyama; Ayumi Osako; Shoko Ono; Mototsugu Kato; Kazuyoshi Yagi; Takashi Hashimoto; Natsumi Tomita; Sho Tsuyama; Tsuyoshi Saito; Kohei Matsumoto; Kenshi Matsumoto; Sumio Watanabe; Naomi Uemura; Tsutomu Chiba; Akihito Nagahara
Journal:  J Gastroenterol       Date:  2021-07-15       Impact factor: 7.527

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.